5-amino-1mq 50mg capsules for NAD+ Metabolism Research 5-Amino-1MQ (50mg/capsule), 60 Capsules -

AOD-9604 is currently sold for research purposes only and lacks regulatory approval from any major health authority worldwide

The detection sensitivity reaches the nanogram level, making it suitable for quantifying trace active ingredients in capsules and related pharmacokinetic studies

Recommended Assessment Tools Body Composition Analysis (Gold Standard): DEXA (Dual-Energy X-ray Absorptiometry) scanning provides precise body fat percentage, lean mass, and visceral fat measurements

The largest published trial (METAOD006/OPTIONS) randomized 502 adults with obesity to AOD-9604 or placebo for 24 weeks alongside a diet and exercise program

Minimal Growth Effects: Unlike full-spectrum hGH, AOD-9604 appears to have a negligible impact on IGF-1 and does not prompt skeletal growth or other widespread hormonal responses